Episode Details
Back to Episodes
Federal Court Blocks Mail Abortion Pills, Supreme Showdown Looms
Description
Federal Appeals Court Blocks Mifepristone Mailings, Threatening Abortion Access Nationwide
A federal appeals court has ruled to block the mailing of mifepristone, the primary abortion pill, across the U.S. This decision, made by the fifth U.S. Circuit Court of Appeals in New Orleans, argues that the FDAs approval of mail delivery clashes with state bans on medical abortions. The ruling comes as a blow to those in states with strict abortion laws, as mail-order pills have been a lifeline since the Supreme Courts 2022 decision to overturn Roe v. Wade. The impact is particularly severe for rural patients, low-income families, people with disabilities, and survivors of abuse, as it limits their access to both abortion and miscarriage care. The ruling sets the stage for a potential Supreme Court showdown, following their 2024 nod to keep mifepristone available, albeit with unanswered questions on standing.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/5f8723f21be1f20e